ATG16L1 and Kawasaki disease: ATG16L1 0.42 (0.34, 0.50) vs. 0.49 (0.41,0.61), BECN1 0.46 (0.41, 0.63) vs. 0.83 (0.66,1), LC3II 0.41 ± 0.21 vs. 0.71 ± 0.19 were significantly downregulated in the IVIG-resistant Kawasaki disease group(P < 0.05), and LAMP2, p62 were not significantly different (Table 5, Fig. 2).